Trending With Impact: Promising Non-Small Cell Lung Cancer Prodrug
August 26, 2021
Researchers examined the preclinical prodrug LP-184 and its efficacy in treating non-small cell lung cancers that lack actionable targets or resistance-related genes. continue reading »